Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO) Syndrome with Henoch–Schönlein Purpura: A Case Report
Ruoyi Wang,Yingzi Li,Yuyue Liu,Xiujuan Hou,Chen Li
DOI: https://doi.org/10.2147/CCID.S392909
2023-04-25
Abstract:Ruoyi Wang, 1, 2, &ast Yingzi Li, 1, 2, &ast Yuyue Liu, 3 Xiujuan Hou, 1, 2, &ast Chen Li 4, &ast 1 Beijing University of Chinese Medicine, Beijing, People's Republic of China; 2 Department of Rheumatology, Dongfang Hospital Beijing University of Chinese Medicine, Beijing, People's Republic of China; 3 Department of Pathology, Dongfang Hospital Beijing University of Chinese Medicine, Beijing, People's Republic of China; 4 Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiujuan Hou; Chen Li, Email ; Introduction: SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome is a rare disease clinically characterized by a wide range of cutaneous and osteoarticular manifestations, involving multiple system impairments. Vasculitis is a rare comorbidity of SAPHO. Henoch–Schönlein purpura (HSP) is a vasculitis involving the capillaries and arterioles mediated by IgA immune complex. No case report of SAPHO syndrome with HSP was ever found. Case: Here we reported a case of SAPHO syndrome complicated with HSP and was successfully treated by methylprednisolone and tofacitinib. Discussion: Although the treat-to-target management of HSP and the first-line clinical medication have given some advices on the treatment. A precise treatment was still needed based on the pathogenesis of the comorbidity. The mechanism of the co-occurrence includes innate immunity and adapted immunity. Considering the active inflammatory reaction and the rapid disease progression, methylprednisolone and tofacitinib were prescribed. Conclusion: HSP is a new comorbidity of SAPHO. The spectrum of cutaneous small-vessel vasculitis in SAPHO syndrome was enriched. A new treatment approach for SAPHO with HSP was provided. Keywords: Henoch–Schönlein purpura, SAPHO syndrome, tofacitinib, vasculitis Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome (SAPHO) syndrome is a rare disease first reported by Chamot et al in 1987. 1 As an auto-inflammatory system disease, SAPHO may involve multiple system impairments. It has been reported that SAPHO could cause vasculitis such as pulmonary vasculitis, 2 retinal vasculitis, 3 and Behçet's disease (BD). 4 So it was obvious that there are some relationships between SAPHO and vasculitis. Henoch–Schönlein Purpura (HSP) is also called immunoglobulin A (IgA) vasculitis. It is a vasculitis involving the capillaries and arterioles mediated by IgA immune complex. HSP was also one of the comorbidities of rheumatoid arthritis 5 and ankylosing spondylitis. 6 So HSP may have similar pathogenesis with auto-inflammation diseases. However, no case report of SAPHO syndrome with HSP was ever found. The etiology is still unknown. There are several similar pathogeneses of the two diseases. Here we described a Chinese young woman with SAPHO syndrome and HSP. However, the treat-to-target management of HSP and the first-line clinical medication have given some advices on the treatment. A more precisely treatment was still needed based on the pathogenesis of the comorbidity. Finally, this case was successfully treated by methylprednisolone and tofacitinib, which provided a valuable asset for the treatment. A 25-year-old Chinese woman presented with palm erythematous in which pinhead-sized intraepidermal pustules formed over 3 years. She was diagnosed as palmoplantar pustulosis (PPP). In the past 3 years, the painful midshaft of the left clavicle and the sternoclavicular joint could be eased with oral diclofenac sodium. However, there existed problems of recurrence. The maculopapular rash in dark purple appeared on the lower extremities (Figure 1A). No indication of fading was observed when pressed. The maculopapular rash rapidly progressed to a wide range. The lesion in the pretibial skin rapidly progressed into a 1-centimeter-sized ulcer (Figure 1B). The patient presented with no swelling or the painful of knee and ankle joints. She also denied a history of allergies and other diseases. Figure 1 The cutaneous manifestation. ( A ) The maculopapular rash in dark purple appeared on the lower extremities; ( B ) The lesion in the pretibial skin rapidly progressed into 1-centimeter-sized ulcer. The laboratory results showed that the amount of platelets was 323×10 5 /L (range, 98–300.2×10 5 /L). The concentration of IgA was 4.93g/L (range, 0.7–4 g/L). The erythrocyte sedimentation ra -Abstract Truncated-
dermatology